(Q73596981)

English

Variability in methotrexate serum and cerebrospinal fluid pharmacokinetics in children with acute lymphocytic leukemia: relation to assay methodology and physiological variables

scientific article published on 01 March 2000

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10739001%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Variability in methotrexate serum and cerebrospinal fluid pharmacokinetics in children with acute lymphocytic leukemia: relation to assay methodology and physiological variables (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10739001%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

acute lymphocytic leukemia

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

H Seidel

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10739001%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

A Andersen

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10739001%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

J T Kvaløy

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10739001%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

R Nygaard

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10739001%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

P J Moe

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10739001%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

G Jacobsen

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10739001%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

B Lindqvist

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10739001%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

L Slørdal

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10739001%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 March 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10739001%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Leukemia Research

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10739001%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10739001%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10739001%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

193-199

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10739001%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Methotrexate systemic clearance influences probability of relapse in children with standard-risk acute lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900181-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Does pharmacokinetic variability influence the efficacy of high-dose methotrexate for the treatment of children with acute lymphoblastic leukemia: what can we learn from small studies?

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900181-2

7 January 2021

based on heuristic

inferred from DOI database lookup

On the prognostic value of systemic methotrexate clearance in childhood acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900181-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Systemic clearance of methotrexate in the prognosis of acute lymphoblastic leukemia in children

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900181-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive intravenous methotrexate and mercaptopurine treatment of higher-risk non-T, non-B acute lymphocytic leukemia: A Pediatric Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900181-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum methotrexate (MTX) concentrations and prognosis in patients with osteosarcoma of the extremities treated with a multidrug neoadjuvant regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900181-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Methotrexate pharmacokinetics and prognosis in osteosarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900181-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: a Scandinavian Sarcoma Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900181-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Intermediate-dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a Pediatric Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900181-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The influence of serum methotrexate concentrations and drug dosage on outcome in childhood acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900181-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900181-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparative study on the pharmacokinetics of methotrexate in a dose range of 0.5 g to 33.6 g/m2 in children with acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900181-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetic variability in the adolescent: implications of body size and organ function for dosage regimen design

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900181-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of HD-MTX in infants, children, and adolescents with non-B acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900181-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Methotrexate infusions in poor prognosis acute lymphoblastic leukemia: II. High-dose methotrexate (HDM) in acute lymphoblastic leukemia in childhood: a pilot study from April 1981

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900181-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Methotrexate plasma pharmacokinetics: importance of assay method

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900181-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900181-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The pharmacology and clinical use of methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900181-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Methotrexate cerebrospinal fluid and serum concentrations after intermediate-dose methotrexate infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900181-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebrospinal fluid drug levels of leukemic children receiving intravenous 5 g/m2 methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900181-2

7 January 2021

based on heuristic

inferred from DOI database lookup

7-Hydroxymethotrexate concentrations in serum and cerebrospinal fluid of children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900181-2

7 January 2021

based on heuristic

inferred from DOI database lookup

CSF drug levels for children with acute lymphoblastic leukemia treated by 5 g/m2 methotrexate. A study from the EORTC Children's Leukemia Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900181-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Methotrexate concentration levels in the cerebrospinal fluid during high-dose methotrexate infusions: an unreliable prediction

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900181-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebrospinal fluid and plasma methotrexate levels following high-dose regimen given as a 3-hour intravenous infusion in children with nonHodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900181-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Anticancer therapy as a pediatric pharmacodynamic paradigm.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900181-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetic interactions with methotrexate: is 7-hydroxy-methotrexate the culprit?

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900181-2

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose 7-hydromethotrexate: acute toxicity and lethality in a rat model

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900181-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Distribution of 7-hydroxymethotrexate in human blood

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900181-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0145-2126(99)00181-2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10739001%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10739001%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73596981&oldid=2210779681"